肿瘤微环境
MAPK/ERK通路
巨噬细胞极化
癌症研究
蛋白激酶A
癌症免疫疗法
免疫系统
细胞生物学
肿瘤相关巨噬细胞
炎症
免疫疗法
癌变
激酶
巨噬细胞
信号转导
生物
癌症
免疫学
体外
生物化学
遗传学
出处
期刊:Journal of Microscopy and Ultrastructure
[Elsevier BV]
日期:2019-01-01
卷期号:7 (2): 53-53
被引量:32
标识
DOI:10.4103/jmau.jmau_68_18
摘要
The notion that inflammation is a critical component of cancer has been researched extensively. Tumor-associated macrophages (TAMs) are among the inflammatory cells that greatly influence cancer. In the tumor microenvironment (TME), macrophages can either stimulate or inhibit tumorigenesis. TAMs that stimulate tumor cell proliferation (M2-phenotype) enrich the TME with growth factors and immunosuppressive molecules, whereas tumor inhibitory TAMs (M1-phenotype) initiate the immune response to dampen tumor progression. Shifting between phenotypes is controlled by several components of the TME. Targeting macrophages, specifically inhibiting M2 TAMs, has been introduced successfully in cancer immunotherapy. However, signaling mechanisms underlining TAM polarization are largely unknown. This review analyzed studies of the role of mitogen-activated protein kinase (MAPK) as a determinant of macrophage polarization. It is proposed that activation of MAPK, particularly extracellular signal-regulated kinase 1/2 and p38, might favor the differentiation into M2 TAMs. Thus, pharmacological modification of MAPK pathways will potentially offer exciting new targets in cancer immunotherapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI